C07C321/22

Substituted bicyclic compounds

Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V): ##STR00001##
and/or a salt thereof, wherein R.sub.1 is —OH or —OP(O)(OH).sub.2, and X.sub.1, X.sub.2, X.sub.3, R.sub.2, R.sub.2a, R.sub.a, R.sub.b, and R.sub.c are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P.sub.1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Substituted bicyclic compounds

Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V): ##STR00001##
and/or a salt thereof, wherein R.sub.1 is —OH or —OP(O)(OH).sub.2, and X.sub.1, X.sub.2, X.sub.3, R.sub.2, R.sub.2a, R.sub.a, R.sub.b, and R.sub.c are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P.sub.1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

METHOD FOR EVALUATING BROMINATED FLAME RETARDERS
20220388951 · 2022-12-08 ·

A process for upgrading brominated flame retardants comprises a) provision of a plastic comprising a flame retardant A consisting of a carbon-based chain substituted by at least two bromine atoms; b) recovery of a composition comprising said flame retardant A; c) bringing said composition comprising said flame retardant A into contact, in an organic solvent, with a compound A′ selected from the group consisting of Na2S2, K2S2, a potassium or sodium alkyl xanthate, and a compound of formula Y—SH in which Y is an alkali metal, an alkaline earth metal, a metal selected from rare earth metals, a —C(NH2)═NH unit or a —C(NR1R2)=NR3 unit; in order to form a mixture C comprising a compound B consisting of a carbon-based chain substituted by at least two —SH functional groups; and d) purification of the mixture C obtained and recovery of said compound B.

METHOD FOR EVALUATING BROMINATED FLAME RETARDERS
20220388951 · 2022-12-08 ·

A process for upgrading brominated flame retardants comprises a) provision of a plastic comprising a flame retardant A consisting of a carbon-based chain substituted by at least two bromine atoms; b) recovery of a composition comprising said flame retardant A; c) bringing said composition comprising said flame retardant A into contact, in an organic solvent, with a compound A′ selected from the group consisting of Na2S2, K2S2, a potassium or sodium alkyl xanthate, and a compound of formula Y—SH in which Y is an alkali metal, an alkaline earth metal, a metal selected from rare earth metals, a —C(NH2)═NH unit or a —C(NR1R2)=NR3 unit; in order to form a mixture C comprising a compound B consisting of a carbon-based chain substituted by at least two —SH functional groups; and d) purification of the mixture C obtained and recovery of said compound B.

SUBSTITUTED BICYCLIC COMPOUNDS

Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V):

##STR00001##

and/or a salt thereof, wherein R.sub.1 is —OH or —OP(O)(OH).sub.2, and X.sub.1, X.sub.2, X.sub.3, R.sub.2, R.sub.2a, R.sub.a, R.sub.b, and R.sub.c are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P.sub.1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

SUBSTITUTED BICYCLIC COMPOUNDS

Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V):

##STR00001##

and/or a salt thereof, wherein R.sub.1 is —OH or —OP(O)(OH).sub.2, and X.sub.1, X.sub.2, X.sub.3, R.sub.2, R.sub.2a, R.sub.a, R.sub.b, and R.sub.c are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P.sub.1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

REMOVAL LIQUID AND METHOD FOR REMOVING OXIDE OF GROUP III-V ELEMENT, TREATMENT LIQUID FOR TREATING COMPOUND OF GROUP III-V ELEMENT, OXIDATION PREVENTION LIQUID FOR PREVENTING OXIDATION OF GROUP III-V ELEMENT, TREATMENT LIQUID FOR TREATING SEMICONDUCTOR SUBSTRATE, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE PRODUCT

Provided are a removal liquid for removing an oxide of a Group III-V element, an oxidation prevention liquid for preventing the oxidation of an oxide of a Group III-V element or a treatment liquid for treating an oxide of a Group III-V element, each liquid including an acid and a mercapto compound; and a method using each of the same liquids. Further provided are a treatment liquid for treating a semiconductor substrate, including an acid and a mercapto compound, and a method for producing a semiconductor substrate product using the same.

REMOVAL LIQUID AND METHOD FOR REMOVING OXIDE OF GROUP III-V ELEMENT, TREATMENT LIQUID FOR TREATING COMPOUND OF GROUP III-V ELEMENT, OXIDATION PREVENTION LIQUID FOR PREVENTING OXIDATION OF GROUP III-V ELEMENT, TREATMENT LIQUID FOR TREATING SEMICONDUCTOR SUBSTRATE, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE PRODUCT

Provided are a removal liquid for removing an oxide of a Group III-V element, an oxidation prevention liquid for preventing the oxidation of an oxide of a Group III-V element or a treatment liquid for treating an oxide of a Group III-V element, each liquid including an acid and a mercapto compound; and a method using each of the same liquids. Further provided are a treatment liquid for treating a semiconductor substrate, including an acid and a mercapto compound, and a method for producing a semiconductor substrate product using the same.

Thiol compounds, synthesis method therefor, and utilization of said thiol compounds

The purpose of the present invention is to provide: novel thiol compounds; a method for synthesizing said thiol compounds; curing agents containing said thiol compounds; resin compositions containing said thiol compounds and an epoxy compound; and resin compositions containing said thiol compounds and an ene compound having a carbon-carbon double bond in a molecule. Furthermore, the purpose of the present invention is to provide adhesives and sealants having these resin compositions as ingredients. The thiol compounds of the present invention are represented by chemical formula (I) to chemical formula (VII).

Thiol compounds, synthesis method therefor, and utilization of said thiol compounds

The purpose of the present invention is to provide: novel thiol compounds; a method for synthesizing said thiol compounds; curing agents containing said thiol compounds; resin compositions containing said thiol compounds and an epoxy compound; and resin compositions containing said thiol compounds and an ene compound having a carbon-carbon double bond in a molecule. Furthermore, the purpose of the present invention is to provide adhesives and sealants having these resin compositions as ingredients. The thiol compounds of the present invention are represented by chemical formula (I) to chemical formula (VII).